#hiv — Friday, May 29, 2026 (3 items)
| 0 | ℹ |
Pharmacological METTL3 inhibition attenuates HIV-1 latency reversal in CD4(+) T cells.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-05-29 | #therapeutics #epigenomics #hiv #latency | |
| 0 | ℹ |
Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations or M184I/V in Proviral DNA.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-05-29 | #amr #clinical trial #hiv #viral_suppression | |
| 0 | ℹ |
Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and Canada.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-05-29 | #infection #metabolism #hiv |